Logiscreen

Emergent Biosolutions Inc

$8.07
Market Cap 417.79M
ROE -1.6%
Gross Margin 53.9%
Debt/Equity 1.1
Current Ratio 4.3
Revenue QoQ -29.7%
EPS QoQ -0.9%
F-Score 3

About

At Emergent, our mission is to protect and enhance life. For over 25 years, we’ve been at work defending people from things we hope will never happen—so we are prepared just in case they ever do. We provide solutions for complex and urgent public health threats through a portfolio of vaccines and therapeutics that we develop and manufacture for governments and consumers. We also offer a range of integrated contract development and manufacturing services for pharmaceutical and biotechnology customers. To learn more about how we help protect public health, visit our website and follow us on LinkedIn, X, Instagram, Apple Podcasts and Spotify.

Exchange
NYSE
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Sector context

Healthcare

Undervalued

Trading at a discount to sector peers

P/E
-50.81
vs median 31.50
P/B
0.84
vs median 2.17
ROE
-0.02
vs median 0.09

Lower quality - review fundamentals carefully

Small-cap company with higher volatility

Similar companies

Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics